News

Warren Buffett has been one of the most quoted people in finance for decades. His straightforward yet insightful advice is remarkably sought after. His often simple yet very effective ideas have helped countless investors better understand the market’s complexities, and all thanks to his decades of expertise and remarkable success. Don't Miss: Amid the ongoing EV revolution, previously overlooked low-income communities now harbor a huge investment opportunity at just $500. ‘Scrolling to UBI': De

Nvidia shares are nearing their all-time highs on continued optimism about sales of its artificial intelligence (AI) chips.

TSMC reported sales figures for September on Wednesday, completing its third quarter data, which came in above what analysts had expected.

(Bloomberg) -- The tech world’s obsession with artificial intelligence is continuing to spur a huge demand for power — supercharging returns in the utilities sector and shaking up the S&P 500 index. Wall Street sees more to come.Most Read from BloombergUrban Heat Stress Is Another Disparity in the World’s Most Unequal NationChicago’s $1 Billion Budget Hole Exacerbated by School TurmoilShould Evictions Be Banned After Hurricanes and Climate Disasters?From Cleveland to Chicago, NFL Teams Dream of

Inbound loads to Lakeland are being rejected at elevated rates. The post Hurricane Milton already impacting Florida freight markets appeared first on FreightWaves.

ARK Invest, the asset management firm founded by Cathie Wood, has divested approximately $36.4 million worth of Robinhood (HOOD) shares, totaling 1.4 million shares, from its three funds.

WeightWatchers (WW International) (NASDAQ:WW) stock is trading higher on Wednesday, with a session volume strong at 31.45 million, compared to an average volume of 3.25 million as per data from Benzinga Pro. WeightWatchers stock is trading higher on continued strength after the company announced on Tuesday that it will add compounded semaglutide to its offering. Semaglutide is an active ingredient in Novo Nordisk A/S’s (NYSE:NVO) ultra popular Wegovy and Ozempic. Over the past year, WeightWatche